BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

10 hedge funds and large institutions have $4.08M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$554K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$907K
2 +$640K
3 +$284K
4
Simplex Trading
Simplex Trading
Illinois
+$99K
5
Morgan Stanley
Morgan Stanley
New York
+$62.4K

Top Sellers

1 -$303K
2 -$19.3K
3 -$983